SALT LAKE CITY, Dec. 30, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc.…
Myriad Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Lynparza® (olaparib) In Patients with Germline BRCA-mutated Metastatic Pancreatic Cancer
